146 related articles for article (PubMed ID: 19439918)
1. The effect of dithiothreitol on chemotactic factors in induced sputum of chronic obstructive pulmonary disease patients.
Wang F; He B
Respiration; 2009; 78(2):217-22. PubMed ID: 19439918
[TBL] [Abstract][Full Text] [Related]
2. Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic saline.
Cianchetti S; Bacci E; Bartoli ML; Ruocco L; Pavia T; Dente FL; Di Franco A; Vagaggini B; Paggiaro P
Clin Exp Allergy; 2007 Dec; 37(12):1819-26. PubMed ID: 17941910
[TBL] [Abstract][Full Text] [Related]
3. Multi-analyte profiling of inflammatory mediators in COPD sputum--the effects of processing.
Pedersen F; Holz O; Lauer G; Quintini G; Kiwull-Schöne H; Kirsten AM; Magnussen H; Rabe KF; Goldmann T; Watz H
Cytokine; 2015 Feb; 71(2):401-4. PubMed ID: 25464927
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease.
Ko FW; Lau CY; Leung TF; Wong GW; Lam CW; Hui DS
Respir Med; 2006 Apr; 100(4):630-8. PubMed ID: 16213701
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
Traves SL; Culpitt SV; Russell RE; Barnes PJ; Donnelly LE
Thorax; 2002 Jul; 57(7):590-5. PubMed ID: 12096201
[TBL] [Abstract][Full Text] [Related]
7. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.
Dentener MA; Vernooy JH; Hendriks S; Wouters EF
Thorax; 2005 Feb; 60(2):114-9. PubMed ID: 15681498
[TBL] [Abstract][Full Text] [Related]
8. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
9. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
[TBL] [Abstract][Full Text] [Related]
10. [Levels of CC-chemokine (MCP-1 alpha, MIP-1 beta) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis].
Barczyk A; Pierzchała W; Sozańska E
Pneumonol Alergol Pol; 2001; 69(1-2):40-9. PubMed ID: 11475557
[TBL] [Abstract][Full Text] [Related]
11. Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.
Toungoussova O; Migliori GB; Foschino Barbaro MP; Esposito LM; Dragonieri S; Carpagnano GE; Salerno FG; Neri M; Spanevello A
Respir Med; 2007 Jul; 101(7):1543-8. PubMed ID: 17258444
[TBL] [Abstract][Full Text] [Related]
12. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
14. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis.
Woolhouse IS; Bayley DL; Stockley RA
Thorax; 2002 Aug; 57(8):667-71. PubMed ID: 12149524
[TBL] [Abstract][Full Text] [Related]
15. Correlation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patients.
Ziora D; Dworniczak S; Kaczmarczyk G; Jastrzebski D; Krzywiecki A; Kozielski J
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):791-9. PubMed ID: 18204193
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
17. [Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
Tian L; Cai L; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):138-40. PubMed ID: 11778483
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemotactic protein-1 in the follicle of the menstrual and IVF cycle.
Dahm-Kähler P; Runesson E; Lind AK; Brännström M
Mol Hum Reprod; 2006 Jan; 12(1):1-6. PubMed ID: 16439481
[TBL] [Abstract][Full Text] [Related]
19. [Microvessel counts and the expressions of chemotactic factors in the pathological scar tissues].
Qian L; Zhao BC; Pi L; Lu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):340-3, 348. PubMed ID: 16045029
[TBL] [Abstract][Full Text] [Related]
20. Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline.
Efthimiadis A; Pizzichini MM; Pizzichini E; Dolovich J; Hargreave FE
Eur Respir J; 1997 Jun; 10(6):1336-40. PubMed ID: 9192939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
